p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway
- PMID: 17468757
- DOI: 10.1038/ng2033
p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway
Abstract
The mitogen-activated protein kinase (MAPK) p38alpha controls inflammatory responses and cell proliferation. Using mice carrying conditional Mapk14 (also known as p38alpha) alleles, we investigated its function in postnatal development and tumorigenesis. When we specifically deleted Mapk14 in the mouse embryo, fetuses developed to term but died shortly after birth, probably owing to lung dysfunction. Fetal hematopoietic cells and embryonic fibroblasts deficient in p38alpha showed increased proliferation resulting from sustained activation of the c-Jun N-terminal kinase (JNK)-c-Jun pathway. Notably, in chemical-induced liver cancer development, mice with liver-specific deletion of Mapk14 showed enhanced hepatocyte proliferation and tumor development that correlated with upregulation of the JNK-c-Jun pathway. Furthermore, inactivation of JNK or c-Jun suppressed the increased proliferation of Mapk14-deficient hepatocytes and tumor cells. These results demonstrate a new mechanism whereby p38alpha negatively regulates cell proliferation by antagonizing the JNK-c-Jun pathway in multiple cell types and in liver cancer development.
Similar articles
-
p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation.Nat Genet. 2007 Jun;39(6):750-8. doi: 10.1038/ng2037. Epub 2007 Apr 29. Nat Genet. 2007. PMID: 17468755
-
p38alpha: a suppressor of cell proliferation and tumorigenesis.Cell Cycle. 2007 Oct 15;6(20):2429-33. doi: 10.4161/cc.6.20.4774. Epub 2007 Oct 21. Cell Cycle. 2007. PMID: 17957136 Review.
-
A new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun pathway inhibition.Biochem J. 2014 Nov 1;463(3):383-92. doi: 10.1042/BJ20140103. Biochem J. 2014. PMID: 25121353 Free PMC article.
-
The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes.Mol Biol Cell. 1998 Mar;9(3):561-73. doi: 10.1091/mbc.9.3.561. Mol Biol Cell. 1998. PMID: 9487126 Free PMC article.
-
Genetic deficiency of p38alpha reveals its critical role in myoblast cell cycle exit: the p38alpha-JNK connection.Cell Cycle. 2007 Jun 1;6(11):1298-303. doi: 10.4161/cc.6.11.4315. Epub 2007 Jun 20. Cell Cycle. 2007. PMID: 17534150 Review.
Cited by
-
p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy.Cancers (Basel). 2024 Jan 6;16(2):256. doi: 10.3390/cancers16020256. Cancers (Basel). 2024. PMID: 38254747 Free PMC article. Review.
-
Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis.J Clin Invest. 2013 Jan;123(1):164-78. doi: 10.1172/JCI65124. Epub 2012 Dec 3. J Clin Invest. 2013. PMID: 23202732 Free PMC article.
-
Obesity, inflammation, and liver cancer.J Hepatol. 2012 Mar;56(3):704-13. doi: 10.1016/j.jhep.2011.09.020. Epub 2011 Nov 25. J Hepatol. 2012. PMID: 22120206 Free PMC article. Review.
-
p38α protein negatively regulates T helper type 2 responses by orchestrating multiple T cell receptor-associated signals.J Biol Chem. 2012 Sep 28;287(40):33215-26. doi: 10.1074/jbc.M112.355594. Epub 2012 Aug 2. J Biol Chem. 2012. PMID: 22859305 Free PMC article.
-
PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway.Mol Cancer Res. 2012 Jun;10(6):810-20. doi: 10.1158/1541-7786.MCR-11-0576. Epub 2012 Jun 4. Mol Cancer Res. 2012. PMID: 22665523 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous